-
1
-
-
0033959520
-
Cancer statistics, 2000
-
Greenlee RT, Murray T, Bolden S, et al: Cancer statistics, 2000. CA Cancer J Clin 50:7-31, 2000.
-
(2000)
CA Cancer J Clin
, vol.50
, pp. 7-31
-
-
Greenlee, R.T.1
Murray, T.2
Bolden, S.3
-
2
-
-
0022876509
-
Survival after postoperative combination treatment of rectal cancer
-
Douglas HO Jr, Moertel CG, Mayer RJ, et al: Survival after postoperative combination treatment of rectal cancer. N Engl J Med 315:1294-1295, 1986.
-
(1986)
N Engl J Med
, vol.315
, pp. 1294-1295
-
-
Douglas Jr., H.O.1
Moertel, C.G.2
Mayer, R.J.3
-
3
-
-
0026071185
-
Effective surgical adjuvant therapy for high-risk rectal carcinoma
-
Krook JE, Moertel CG, Gunderson LL, et al: Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 324:709-715, 19991.
-
(1991)
N Engl J Med
, vol.324
, pp. 709-715
-
-
Krook, J.E.1
Moertel, C.G.2
Gunderson, L.L.3
-
4
-
-
0028136295
-
Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery
-
O'Connell MJ, Martenson JA, Wieand HS, et al: Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 331:502-507, 1994.
-
(1994)
N Engl J Med
, vol.331
, pp. 502-507
-
-
O'Connell, M.J.1
Martenson, J.A.2
Wieand, H.S.3
-
5
-
-
0026721532
-
Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rates
-
Advanced Colorectal Cancer Meta-Analysis Project: Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rates. J Clin Oncol 10:896-903, 1992.
-
(1992)
J Clin Oncol
, vol.10
, pp. 896-903
-
-
-
6
-
-
0030994521
-
Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: Initial results of Intergroup 0114
-
Tepper JE, O'Connell MJ, Petroni GR, et al: Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: Initial results of Intergroup 0114. J Clin Oncol 15:2030-2039, 1997.
-
(1997)
J Clin Oncol
, vol.15
, pp. 2030-2039
-
-
Tepper, J.E.1
O'Connell, M.J.2
Petroni, G.R.3
-
7
-
-
0032799672
-
Adjuvant postoperative combined-modality therapy for rectal cancer
-
Minsky BD: Adjuvant postoperative combined-modality therapy for rectal cancer. Oncology (Huntington) 13(suppl 3):132-135, 1999.
-
(1999)
Oncology (Huntington)
, vol.13
, Issue.3 SUPPL.
, pp. 132-135
-
-
Minsky, B.D.1
-
8
-
-
0031017851
-
Patient preference for oral vs intravenous palliative chemotherapy
-
Liu G, Franssen E, Fitch MI, Warner E: Patient preference for oral vs intravenous palliative chemotherapy. J Clin Oncol 15:110-115, 1997.
-
(1997)
J Clin Oncol
, vol.15
, pp. 110-115
-
-
Liu, G.1
Franssen, E.2
Fitch, M.I.3
Warner, E.4
-
9
-
-
0031868962
-
UFT and leucovorin: A review of its clinical development and therapeutic potential in the oral treatment of cancer
-
Hoff PM, Pazdur R, Benner SE, et al: UFT and leucovorin: A review of its clinical development and therapeutic potential in the oral treatment of cancer. Anticancer Drugs 9:479-490, 1998.
-
(1998)
Anticancer Drugs
, vol.9
, pp. 479-490
-
-
Hoff, P.M.1
Pazdur, R.2
Benner, S.E.3
-
10
-
-
0027650899
-
A comparison of 5-fluorouracil concentration of 5-fluorouracil drip infusion vs oral UFT in plasma of same patients
-
Hirata K, Sasaki K, Yamamitsu S, Shiraska T: A comparison of 5-fluorouracil concentration of 5-fluorouracil drip infusion vs oral UFT in plasma of same patients [in Japanese]. Jpn J Cancer Chemother 20:1409-1411, 1993.
-
(1993)
Jpn J Cancer Chemother
, vol.20
, pp. 1409-1411
-
-
Hirata, K.1
Sasaki, K.2
Yamamitsu, S.3
Shiraska, T.4
-
11
-
-
0031691506
-
Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous infusion and oral uracil plus N1-(2′-tetrahydrofuryl)-5-fluorouracil
-
Ho DH, Pazdur R, Covington W, et al: Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous infusion and oral uracil plus N1-(2′-tetrahydrofuryl)-5-fluorouracil. Clin Cancer Res 4:2085-2088, 1998.
-
(1998)
Clin Cancer Res
, vol.4
, pp. 2085-2088
-
-
Ho, D.H.1
Pazdur, R.2
Covington, W.3
-
12
-
-
0031043439
-
Augmentation of the chemotherapeutic effectiveness of UFT, a combination of tegafur [1-(2-tetrahydrofuryl)-5-fluorouracil] with uracil, by oral 1-leucovorin
-
Okabe H, Toko T, Saito H, et al: Augmentation of the chemotherapeutic effectiveness of UFT, a combination of tegafur [1-(2-tetrahydrofuryl)-5-fluorouracil] with uracil, by oral 1-leucovorin. Anticancer Res 17:157-164, 1997.
-
(1997)
Anticancer Res
, vol.17
, pp. 157-164
-
-
Okabe, H.1
Toko, T.2
Saito, H.3
-
13
-
-
0000082787
-
Multicenter phase III study of 5-fluorouracil (5-FU) UFT in combination with leucovorin (LV) in patients with metastatic colorectal cancer
-
abstract 1009
-
Pazdur R, Douillard J-Y, Skillings JR, et al: Multicenter phase III study of 5-fluorouracil (5-FU) UFT in combination with leucovorin (LV) in patients with metastatic colorectal cancer (abstract 1009). Proc Am Soc Clin Oncol 18:263, 1999.
-
(1999)
Proc Am Soc Clin Oncol
, vol.18
, pp. 263
-
-
Pazdur, R.1
Douillard, J.-Y.2
Skillings, J.R.3
-
14
-
-
0001073793
-
Randomized comparative study of ORZEL (oral uracil/tegafur [UFT] plus leucovorin [LV]) vs parenteral 5-fluorouracil (5-FU) in patients with metastatic colorectal cancer
-
abstract 1015
-
Carmichael J, Popiela T, Radstone D, et al: Randomized comparative study of ORZEL (oral uracil/tegafur [UFT] plus leucovorin [LV]) vs parenteral 5-fluorouracil (5-FU) in patients with metastatic colorectal cancer (abstract 1015). Proc Am Soc Clin Oncol 18:264a, 1999.
-
(1999)
Proc Am Soc Clin Oncol
, vol.18
-
-
Carmichael, J.1
Popiela, T.2
Radstone, D.3
-
15
-
-
0031671241
-
Sphincter preservation in rectal cancer with preoperative radiation therapy and coloanal anastomosis: Long- Term follow-up
-
Wagman R, Minsky BD, Cohen AM, et al: Sphincter preservation in rectal cancer with preoperative radiation therapy and coloanal anastomosis: Long- term follow-up. Int J Radiat Oncol Biol Phys 42:51-57, 1998.
-
(1998)
Int J Radiat Oncol Biol Phys
, vol.42
, pp. 51-57
-
-
Wagman, R.1
Minsky, B.D.2
Cohen, A.M.3
-
16
-
-
0030975222
-
Infusional chemoradiation for operable rectal cancer: Post-, pre-, or nonoperative management?
-
Rich TA: Infusional chemoradiation for operable rectal cancer: Post-, pre-, or nonoperative management? Oncology (Huntington) 11:295-300, 1997.
-
(1997)
Oncology (Huntington)
, vol.11
, pp. 295-300
-
-
Rich, T.A.1
-
17
-
-
0031602151
-
Sphincter preservation in rectal cancer. Preoperative radiation therapy followed by low anterior resection with coloanal anastomosis
-
Minsky BD: Sphincter preservation in rectal cancer. Preoperative radiation therapy followed by low anterior resection with coloanal anastomosis. Semin Radial Oncol 8:30-35, 1998.
-
(1998)
Semin Radial Oncol
, vol.8
, pp. 30-35
-
-
Minsky, B.D.1
-
18
-
-
0028099423
-
Phase II trial of uracil and tegafur plus oral leucovorin: An effective oral regimen in the treatment of metastatic colorectal carcinoma
-
Pazdur R, Lassere Y, Rhodes V, et al: Phase II trial of uracil and tegafur plus oral leucovorin: An effective oral regimen in the treatment of metastatic colorectal carcinoma. J Clin Oncol 12:2296-2300, 1994.
-
(1994)
J Clin Oncol
, vol.12
, pp. 2296-2300
-
-
Pazdur, R.1
Lassere, Y.2
Rhodes, V.3
|